Inovalon Holdings, Inc. (INOV)
$41.06
Rating:
Recommendation:
Neutral
| Symbol | INOV |
|---|---|
| Price | $41.06 |
| Beta | 0.529 |
| Volume Avg. | 0.81M |
| Market Cap | - |
| Shares () | - |
| 52 Week Range | 40.98-41.06 |
| 1y Target Est | - |
| DCF Unlevered | INOV DCF -> | |
|---|---|---|
| DCF Levered | INOV LDCF -> | |
| ROE | 3.23% | Neutral |
| ROA | 1.15% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 126.61% | Buy |
| P/E | - | |
| P/B | 8.67 | Strong Buy |
Latest INOV news
About
Download (Excel)Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.